Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Equine viral arteritis confirmed in Devon
“A full investigation is continuing to determine the source and possible spread of the infection." (Stock photo)
Mares and stallions ‘should be tested before breeding’
 
Defra has confirmed a case of equine viral arteritis (EVA) in a non-thoroughbred stallion on a premises in Devon.

The horse had close epidemiological links with a premises in Dorset, where the disease was confirmed in three stallions in April.

Restrictions on breeding have been placed on the affected animal to reduce the risk of disease spreading.

Chief veterinary officer Christine Middlemiss said: “A full investigation is continuing to determine the source and possible spread of the infection. Owners of mares and stallions are urged to have their animals tested before they are used for breeding.

“These findings remind us that we must all be vigilant for signs of disease and follow strict biosecurity measures.”

Defra advises the following measures to prevent the spread of EVA:
  • following the Horserace Betting Levy Board Code of Practice
  • testing animals before they are used for breeding
  • considering vaccinating stallions against the disease
  • practising good biosecurity.

EVA is a notifiable disease in all stallions, and in mares that have been mated or inseminated in the previous 14 days. Any suspected cases must be reported to APHA immediately by calling the Defra Rural Services helpline on 03000 200 301. There is no risk to public health.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.